REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression
Minsik Park(Kangwon National University), Young‐Myeong Kim(Kangwon National University)
Cited by 16
Related Papers
Ginseng Berry Extract Prevents Atherogenesis via Anti-Inflammatory Action by Upregulating Phase II Gene Expression
|Evidence-based Complementary and Alternative Medicine|2012|48
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
|Nature Communications|2022|28